Method for reducing surgical need in patients with benign prostatic hyperplasia

摘要

Embodiments of the invention include methods of treating a condition that requires the removal or destruction of cellular elements, such as benign or malignant tumors, using a small peptide-based compound in combination with an additional active agent. In this method, the compound is administered intramuscularly, orally, intravenously, intrathecally, intratumorally, intranasally, topically, transdermally, alone or as a carrier to the mammal in need. Administration in combination with, but not limited to. Implementing this method unexpectedly reduces the need for subsequent invasive surgical procedures.